Formation Bio Lands $372M Series D Amid AI-Driven Expansion

Formation Bio Secures $372M Series D Backed by Sanofi to Enhance AI-Driven Drug Development

Sanofi and other key investors have propelled Formation Bio forward with an impressive $372 million Series D funding. Unlike extravagant AI promises, Formation Bio focuses on practical solutions, automating workflows in the biotech industry. This includes generating tailored patient recruitment content for clinical trials and quickly producing AI-generated adverse event reports.